EU Reach Political Agreement onAIAct – Key Areas of Impact for Life Sciences Companies
Sidley Austin As such, medical devices and IVDs (devices) of class IIa and above will be subject to the requirements of theAIAct applying to “high-risk”AI …
Read the original at Key Areas of Impact for Life Sciences Companies ↗
- Topics
- Healthcare
- Mentions
- European Union
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”